e-NIOS Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
e-NIOS General Information
Description
Developer of cloud-based bioinformatics systems intended for multi-omic data interpretation purposes. The company's platform applies explainable artificial intelligence and semantic processing to analyze high-dimensional omic datasets, map findings to biological pathways, and support biomarker identification and target prioritization workflows, enabling researchers and pharmaceutical organizations to obtain interpretable insights for pre-clinical drug development and precision medicine use cases.
Contact Information
Website
e-nios.comCorporate Office
- L. Syggrou 196
- Kallithea
- Athens, Attiki 176 71
- Greece
Corporate Office
- L. Syggrou 196
- Kallithea
- Athens, Attiki 176 71
- Greece
e-NIOS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 28-Jul-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Jan-2017 | Completed | Generating Revenue | |||
| 2. Seed Round | 14-Dec-2015 | $215K | $215K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
e-NIOS Comparisons
Industry
Financing
Details
e-NIOS Competitors (3)
One of e-NIOS’s 3 competitors is Qiagen, a Formerly VC-backed company based in Hilden, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Qiagen | Formerly VC-backed | Hilden, Germany | ||||
| Sophia Genetics | Formerly VC-backed | Rolle, Switzerland | ||||
| Roche Diagnostics | Corporation | Rotkreuz, Switzerland |
e-NIOS Patents
e-NIOS Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3861022-A1 | Methods and pharmaceutical composition for the treatment of mucosal inflammatory diseases | Pending | 04-Oct-2018 | ||
| US-20210340278-A1 | Methods and pharmaceutical composition for the treatment of mucosal inflammatory diseases | Pending | 04-Oct-2018 | ||
| WO-2020070240-A1 | Methods and pharmaceutical composition for the treatment of mucosal inflammatory diseases | Inactive | 04-Oct-2018 | ||
| JP-2022512626-A | Methods and pharmaceutical compositions for the treatment of mucosal inflammatory diseases | Active | 04-Oct-2018 | ||
| JP-7592585-B2 | Methods and pharmaceutical compositions for the treatment of mucosal inflammatory diseases | Active | 04-Oct-2018 | C07K16/40 |
e-NIOS Signals
e-NIOS Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pfizer | Corporation |
e-NIOS FAQs
-
When was e-NIOS founded?
e-NIOS was founded in 2013.
-
Where is e-NIOS headquartered?
e-NIOS is headquartered in Athens, Greece.
-
What is the size of e-NIOS?
e-NIOS has 8 total employees.
-
What industry is e-NIOS in?
e-NIOS’s primary industry is Business/Productivity Software.
-
Is e-NIOS a private or public company?
e-NIOS is a Private company.
-
What is e-NIOS’s current revenue?
The current revenue for e-NIOS is .
-
How much funding has e-NIOS raised over time?
e-NIOS has raised $367K.
-
Who are e-NIOS’s investors?
Pfizer has invested in e-NIOS.
-
Who are e-NIOS’s competitors?
Qiagen, Sophia Genetics, and Roche Diagnostics are competitors of e-NIOS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process